Long-acting antiretrovirals: a new era for the management and prevention of HIV infection
出版年份 2021 全文链接
标题
Long-acting antiretrovirals: a new era for the management and prevention of HIV infection
作者
关键词
-
出版物
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2021-08-18
DOI
10.1093/jac/dkab324
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy, pharmacokinetics and safety over 48 weeks with ibalizumab-based therapy in treatment-experienced adults infected with HIV-1
- (2021) Joseph C. Gathe et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine
- (2021) Amy G. Cutrell et al. AIDS
- Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
- (2021) Daryl Hodge et al. CLINICAL PHARMACOKINETICS
- Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial
- (2021) Jean-Michel Molina et al. Lancet HIV
- Therapeutic review of cabotegravir/rilpivirine long‐acting antiretroviral injectable and implementation considerations at an HIV specialty clinic
- (2021) Zach W. Howe et al. PHARMACOTHERAPY
- Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection
- (2020) Chloe Orkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
- (2020) Susan Swindells et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib
- (2020) Thierry Buclin et al. Frontiers in Pharmacology
- Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial
- (2020) Dirk Schürmann et al. Lancet HIV
- Comparative Clinical Pharmacokinetics a1 nd Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors: An Updated Review
- (2020) Anthony T. Podany et al. CLINICAL PHARMACOKINETICS
- Advances in Long-Acting Agents for the Treatment of HIV Infection
- (2020) Aadia I. Rana et al. DRUGS
- A year-long extended release nanoformulated cabotegravir prodrug
- (2020) Tanmay A. Kulkarni et al. NATURE MATERIALS
- Design of a Drug-Eluting Subcutaneous Implant of the Antiretroviral Tenofovir Alafenamide Fumarate
- (2020) Solange M Simpson et al. PHARMACEUTICAL RESEARCH
- Effectiveness of vaginal microbicides in preventing HIV transmission
- (2020) Alfred Musekiwa et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Recent advances in long-acting nanoformulations for delivery of antiretroviral drugs
- (2020) Dhanashree H. Surve et al. JOURNAL OF CONTROLLED RELEASE
- Understanding the Acceptability of Subdermal Implants as a Possible New HIV Prevention Method: Multi-Stage Mixed Methods Study
- (2020) Christine Tagliaferri Rael et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- Clinical targeting of HIV capsid protein with a long-acting small molecule
- (2020) John O. Link et al. NATURE
- Long-acting antiretroviral therapy
- (2020) Vicente Soriano et al. NATURE MATERIALS
- Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial
- (2020) Raphael J Landovitz et al. Lancet HIV
- Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options
- (2020) Karine Dubé et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Antibody-based strategies in HIV therapy
- (2020) Wesley D. Kufel INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
- (2020) Michael S. Saag et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Exploration into the opinions of patients with HIV, healthcare professionals and the lay public of the use of microneedles in clinical practice: highlighting the translational potential for their role in HIV infection
- (2020) Kurtis Moffatt et al. Drug Delivery and Translational Research
- Long-acting drugs and formulations for the treatment and prevention of HIV infection
- (2020) Charles Flexner et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study
- (2020) Edgar T Overton et al. LANCET
- Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV Prophylaxis
- (2020) Manjula Gunawardana et al. Frontiers in Pharmacology
- Long-acting injectable HIV therapies: the next frontier
- (2020) John Thornhill et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Antiretroviral Adherence Level Necessary for HIV Viral Suppression using Real-World Data
- (2019) Kathy K. Byrd et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Potential user interest in new long-acting contraceptives: Results from a mixed methods study in Burkina Faso and Uganda
- (2019) Rebecca L. Callahan et al. PLoS One
- Characterization of a Reservoir-Style Implant for Sustained Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP)
- (2019) Leah M. Johnson et al. Pharmaceutics
- Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline
- (2019) Lara Esteves Coelho et al. Lancet HIV
- Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research priorities
- (2019) Sharon Nachman et al. Lancet HIV
- Creation of a long-acting rilpivirine prodrug nanoformulation
- (2019) James R. Hilaire et al. JOURNAL OF CONTROLLED RELEASE
- Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery
- (2019) S. Rahima Benhabbour et al. Nature Communications
- LB8. Microarray Patch Delivery of Long-Acting HIV PrEP and Contraception
- (2019) Annie Rein-Weston et al. Open Forum Infectious Diseases
- Long-acting injectable therapy
- (2019) Ronald D’Amico et al. Current Opinion in HIV and AIDS
- Long-acting implants to treat and prevent HIV infection
- (2019) Ethel D. Weld et al. Current Opinion in HIV and AIDS
- Islatravir for the treatment and prevention of infection with the human immunodeficiency virus type 1
- (2019) Martin Markowitz et al. Current Opinion in HIV and AIDS
- Long-acting injectable cabotegravir for the prevention of HIV infection
- (2019) Meredith E. Clement et al. Current Opinion in HIV and AIDS
- Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV
- (2019) Perrine Courlet et al. Open Forum Infectious Diseases
- Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles
- (2018) Tian Zhou et al. BIOMATERIALS
- Ibalizumab: First Global Approval
- (2018) Anthony Markham DRUGS
- Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies
- (2018) Josep M Llibre et al. LANCET
- Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals
- (2018) Tian Zhou et al. Nanomedicine
- Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women
- (2018) Andrea Ries Thurman et al. PLoS One
- Rilpivirine long-acting for the prevention and treatment of HIV infection
- (2018) Francesca Ferretti et al. Current Opinion in HIV and AIDS
- Antiretroviral implants for treatment and prevention of HIV infection
- (2018) Charles Flexner Current Opinion in HIV and AIDS
- Treatment and prevention of HIV infection with long-acting antiretrovirals
- (2018) Laura Benítez-Gutiérrez et al. Expert Review of Clinical Pharmacology
- Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis
- (2018) Corrine Ying Xuan Chua et al. JOURNAL OF CONTROLLED RELEASE
- Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1
- (2018) Brinda Emu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Acting HIV Drugs for Treatment and Prevention
- (2018) Roy M. Gulick et al. Annual Review of Medicine
- Pharmacokinetics and Pharmacodynamics of Cabotegravir, a Long-Acting HIV Integrase Strand Transfer Inhibitor
- (2018) Dario Cattaneo et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension
- (2018) Maelíosa T.C. Mc Crudden et al. JOURNAL OF CONTROLLED RELEASE
- Ultra-long-acting removable drug delivery system for HIV treatment and prevention
- (2018) Martina Kovarova et al. Nature Communications
- Creating demand for long-acting formulations for the treatment and prevention of HIV, tuberculosis, and viral hepatitis
- (2018) Charles Flexner et al. Current Opinion in HIV and AIDS
- Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
- (2017) David A Margolis et al. LANCET
- Long-acting injectable ART: next revolution in HIV?
- (2017) Mark A Boyd et al. LANCET
- Long-Acting Antiretrovirals: Where Are We now?
- (2017) Amesika N Nyaku et al. Current HIV/AIDS Reports
- Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial
- (2017) Martin Markowitz et al. Lancet HIV
- Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy
- (2016) Andrew Owen et al. ADVANCED DRUG DELIVERY REVIEWS
- Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals
- (2016) Manel Aouri et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women
- (2016) Annalene Nel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
- (2016) Jared M. Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients
- (2016) Baralee Punyawudho et al. Expert Review of Clinical Pharmacology
- Pharmacokinetics of Long-Acting Tenofovir Alafenamide (GS-7340) Subdermal Implant for HIV Prophylaxis
- (2015) Manjula Gunawardana et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial
- (2015) David A Margolis et al. LANCET INFECTIOUS DISEASES
- Drug interaction profile of the HIV integrase inhibitor cabotegravir: assessment fromin vitrostudies and a clinical investigation with midazolam
- (2015) Melinda J. Reese et al. XENOBIOTICA
- Formulation and pharmacology of long-acting rilpivirine
- (2015) Peter E. Williams et al. Current Opinion in HIV and AIDS
- Formulation and pharmacology of long-acting cabotegravir
- (2015) Christine Trezza et al. Current Opinion in HIV and AIDS
- Adherence to Preexposure Prophylaxis: Current, Emerging, and Anticipated Bases of Evidence
- (2014) K. Rivet Amico et al. CLINICAL INFECTIOUS DISEASES
- A Compartmental Pharmacokinetic Evaluation of Long-Acting Rilpivirine in HIV-Negative Volunteers for Pre-Exposure Prophylaxis
- (2014) A G A Jackson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetics of the etonogestrel contraceptive implant in obese women
- (2012) Sara Mornar et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Androgens and doping tests: genetic variation and pit-falls
- (2012) Anders Rane et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
- (2012) Jared M. Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
- (2010) Robert M. Grant et al. NEW ENGLAND JOURNAL OF MEDICINE
- TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1
- (2009) H. Azijn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now